IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2024-09-14 (hitnews.co.kr)
Biosecurity Act passed by the U.S. House of Representatives... K Pharmaceutical Bio plants its flag in Spain
With the U.S. House of Representatives recently passing the Biosecurity Act, which aims to sanction Chinese biotechnology companies, expectations are growing that domestic biopharmaceutical contract development and manufacturing (CDMO) companies will benefit. This is because the reorganization of the global supply chain due to the Biosecurity Act is expected to act as both an opportunity and a challenge for the Korean biopharmaceutical industry. Dear readers, I hope you make long-awaited happy memories with your family during the five-day Chuseok holiday from the 14th to the 18th. The first news of the weekly briefing was 'The life that crossed the threshold of the U.S. House of Representatives'
Read more